Welcome: Stephanie Lo

Why It Matters

Accurate protein function data underpins AI‑driven research, enabling faster drug and vaccine development against infectious threats. Strengthening bacterial protein annotations directly benefits antimicrobial‑resistance surveillance worldwide.

Key Takeaways

• Lo leads UniProt protein function curation at EMBL‑EBI.
• GPS project experience links genomics to protein insights.
• AI model ProtNLM trained on UniProtKB accelerates annotation.
• Focus on bacterial proteins and antimicrobial resistance.
• International collaborations ensure comprehensive, accessible protein data.

Pulse Analysis

Manual protein annotation remains a cornerstone of modern bioinformatics, providing the gold‑standard reference that fuels computational models. UniProt, the premier repository for protein sequences and functional descriptions, relies on expert curators to translate experimental findings into structured Gene Ontology terms. This high‑quality groundwork is essential for training machine‑learning systems, ensuring that AI predictions inherit the rigor of human expertise while expanding coverage to millions of uncharacterized proteins.

Stephanie Lo’s transition from the Global Pneumococcal Sequencing (GPS) initiative to EMBL‑EBI illustrates the growing convergence of genomics and protein science. At GPS, she examined bacterial DNA to track evolution and vaccine relevance, a perspective that now informs her focus on protein function in pathogenic microbes. Tools like AlphaFold have demystified protein structures, but interpreting how mutations alter function—particularly in resistance enzymes—still demands curated functional data. Lo’s background equips her to bridge these domains, sharpening insights into antimicrobial resistance mechanisms.

Looking ahead, the integration of AI models such as ProtNLM—co‑developed with Google DeepMind—promises to multiply the speed and consistency of protein annotation. By training on UniProtKB’s meticulously curated entries, ProtNLM can predict functions for novel sequences, accelerating research pipelines for antibiotics and vaccines. Coupled with EMBL‑EBI’s international partnerships, this hybrid human‑AI workflow ensures that protein knowledge remains accurate, comprehensive, and freely accessible, reinforcing the global fight against emerging infectious diseases.